Stellantis Streamlines Portfolio Pivots to Four Core Brands in FaSTLAne 2030 Plan Trumps Iran Deal Faces Republican Skepticism Amid Asset Unfreeze SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development Eli Lillys Retatrutide Shows Strong Phase 3 Results CNBC Reports Bank of America Projects Fed Rate Cuts Unlikely Until Second Half of 2027 CBS News Report ColgatePalmolive India Shifts Strategy Toward Premium Oral Care and DigitalFirst Growth CRSR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction SRBK Q3 2025 Earnings Modest Profitability Amid Quiet Market Reaction LILA Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Victory Capital Holdings Inc VCTR Q1 2026 Earnings EPS Tops Estimates as Asset Manager Delivers Solid Profit Performance FRAF Q1 2026 Earnings Earnings Beat Estimates on 828 Surprise Shares Edge Higher Compugen Ltd Q1 2026 Earnings Narrowing Losses but Misses Estimates ICON plc Surges 1545 Strong Momentum Tests Resistance Air Industries Group AIRI Rallies to 307 Testing Key Resistance Levels BlackRock Health Sciences Term Trust BMEZ Holds Steady Near Support as Sector Momentum Builds Sempra SRE Edges Lower as Utility Sector Faces Headwinds ProDex Inc PDEX Edges Higher Testing Resistance at 6670 Spotify Shares Surge 13 After AI Music Deal with Universal Music Group and Upbeat Guidance iQSTEL Inc Q4 2025 Earnings EPS Misses Estimates Significantly Bloomin Brands Stock Dips 243 Testing Support Levels Amid Market Pressures RRC Q1 2026 Earnings EPS Surges Past Estimates with 19 Beat Amid Strategic Operations AEE Q1 2026 Earnings EPS Beats Estimates as Utility Gains on Operational Efficiency DEO Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Beneficient BENF Q1 2026 Earnings Massive EPS Beat on Positive Net Income but Shares Slide Datadog Q1 2026 Earnings EPS Surges Past Estimates as Strong Profitability Drives Stock Higher QRHC Q1 2026 Earnings EPS Miss Highlights Operational Headwinds and Cost Pressures PDSB Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Progress Continues